Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA)

99 filings reported holding NMRA - Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value as of Q1 2024.
Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 52,696,596 shares of 164,052,981 outstanding shares and own 32% of the company stock.
Largest 10 shareholders include SOFTBANK GROUP CORP. (7,646,916 shares), FMR LLC (7,482,365 shares), MIC Capital Management UK LLP (4,460,700 shares), T. Rowe Price Investment Management, Inc. (3,584,004 shares), ICONIQ Capital, LLC (3,398,628 shares), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST (3,309,123 shares), Artal Group S.A. (2,924,052 shares), EcoR1 Capital, LLC (2,071,450 shares), JOHNSON & JOHNSON (1,849,445 shares), and CITADEL ADVISORS LLC (1,823,983 shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.